What one share of Evotec SE holds
At Evotec, we envision drug discovery, preclinical development, and manufacturing as a seamless continuum. Our ambition is to lead the way by combining comprehensive disease understanding at the molecular level with cutting-edge technologies, transforming this knowledge into precise, life-changing medicines through collaborative partnerships.
Evotec SE’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $2.51 |
|---|---|
| Profit | −$0.33 |
| Capex (buildings and equipment) | $0.23 |
| Free cash flow | −$0.26 |
| Cash and investments | $1.38 |
| Debt | $0.91 |
| Book value | $2.69 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $1.67 | $0.14 | $0.12 | $0.04 | — | $1.79 |
| 2020 | $1.86 | $0.02 | $0.37 | −$0.20 | — | $2.70 |
| 2021 | $2.20 | $0.77 | $0.42 | $0.03 | — | $4.41 |
| 2022 | $2.24 | −$0.52 | $0.54 | $0.07 | — | $3.59 |
| 2023 | $2.39 | −$0.26 | $0.65 | −$0.54 | — | $3.50 |
| 2024 | $2.43 | −$0.60 | $0.36 | −$0.30 | — | $2.78 |
| 2025 | $2.51 | −$0.33 | $0.23 | −$0.26 | — | $2.69 |
Common questions about Evotec SE
How much does one share of Evotec SE earn?
Over its latest fiscal year, Evotec SE lost $0.33 for each share on $2.51 of sales.
Does Evotec SE pay a dividend?
Evotec SE didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Evotec SE’s book value per share?
Evotec SE’s book value is $2.69 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of Evotec SE have?
Each share of Evotec SE has $1.38 of cash and investments and $0.91 of debt, as of December 31, 2025.
What is Evotec SE’s free cash flow per share?
−$0.26 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Evotec SE bought back shares?
Evotec SE’s share count rose about 19% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.